ID   CCMCL1
AC   CVCL_RU10
SY   Cleveland Clinic Mantle Cell Lymphoma 1
DR   Millipore; SCC132
DR   Wikidata; Q54808982
RX   PubMed=25907904;
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): Millipore=SCC132
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D18S51: 15,16
ST   D21S11: 31,32.2
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   D8S1179: 13,14
ST   FGA: 19,22.2
ST   Penta D: 12,13
ST   Penta E: 5,7
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 14,18
DI   NCIt; C4337; Mantle cell lymphoma
DI   ORDO; Orphanet_52416; Mantle cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 7
//
RX   PubMed=25907904; DOI=10.1182/blood-2015-01-622795; PMCID=PMC4432548;
RA   Zhao X.-X., Chen-Kiang S., Shetty S., Di Liberto M., Bodo J., Durkin L.,
RA   Eng K., Elemento O., Smith M.R., Hsi E.D.;
RT   "CCMCL1: a new model of aggressive mantle cell lymphoma.";
RL   Blood 125:2730-2732(2015).
//